Review Article
Tailored Extracellular Vesicles: Novel Tool for Tissue Regeneration
Table 2
Modified EVs in the therapy eye-related diseases.
| Diseases | EV Sources | Specific substrates | Modification methods | Modified EVs | Biological effects | Ref. |
| Pathological retinal angiogenesis | EC | Anchoring peptide CP05; KV11 peptide | Link therapeutic peptide to EV via anchoring peptide | KV11-CP05-EV | Less neovascularization and vessel leakage | [62] | CNV | Treg | VEGF antibody | Conjugate antibody to EV via a peptide linker (cL) | CL-aV-EV | Inhibition of inflammation and VEGF activity | [63] |
|
|